Form 4 Tracker
IONIS PHARMACEUTICALS INC
IONS

63 insider filings · Latest: Jun 26, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 31, 2025Jan 31 10:43 PMSchneider Eugene
Proposed Sale
1,700$33.00$56.1K

View →

Jan 31, 2025Jan 31 10:41 PMGeary Richard S
Proposed Sale
1,910$35.00$66.8K

View →

Jan 31, 2025Jan 31 10:03 PMSwayze Eric
Proposed Sale
1,857$35.00$65.0K

View →

Jan 31, 2025Jan 31 10:02 PMO'NEIL PATRICK R.
Proposed Sale
1,910$35.00$66.8K

View →

Jan 31, 2025Jan 31 10:01 PMHOUGEN ELIZABETH L
Proposed Sale
2,069$35.00$72.4K

View →

Jan 31, 2025Jan 31 9:59 PMBENNETT C FRANK
Proposed Sale
1,803$35.00$63.1K

View →

Jan 31, 2025Jan 31 9:58 PMMonia Brett P
Proposed Sale
13,242$33.53$444.0K

View →

Jan 16, 2025Jan 17 12:31 AMSwayze Eric
Proposed Sale
7,154$32.70$233.9K

View →

Jan 16, 2025Jan 17 12:30 AMSchneider Eugene
Proposed Sale
6,523$32.70$213.3K

View →

Jan 16, 2025Jan 17 12:29 AMO'NEIL PATRICK R.
Proposed Sale
7,360$32.70$240.7K

View →

Jan 16, 2025Jan 17 12:28 AMMonia Brett P
Proposed Sale
33,445$32.70$1.1M

View →

Jan 16, 2025Jan 17 12:25 AMHOUGEN ELIZABETH L
Proposed Sale
8,870$32.70$290.0K

View →

Jan 16, 2025Jan 17 12:23 AMGeary Richard S
Proposed Sale
7,072$32.70$231.3K

View →

Jan 16, 2025Jan 17 12:22 AMDevers Shannon L.
Proposed Sale
4,267$32.70$139.5K

View →

Jan 16, 2025Jan 17 12:21 AMBirchler Brian
Proposed Sale
5,400$32.70$176.6K

View →

Jan 16, 2025Jan 17 12:19 AMBENNETT C FRANK
Proposed Sale
6,752$32.70$220.8K

View →

Jan 16, 2025Jan 17 12:18 AMBaroldi Joseph
Proposed Sale
3,401$32.70$111.2K

View →

Nov 12, 2024Nov 13 1:55 PMMonia Brett P
Proposed Sale
6,630$38.88$257.8K

View →

Nov 12, 2024Nov 12 9:17 PMMonia Brett P
Proposed Sale
6,629$38.89$257.8K

View →

Nov 12, 2024Nov 12 9:16 PMSwayze Eric
Proposed Sale
1,194$38.88$46.4K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 9, 2026Mar 11 8:19 PMBrett P MoniaDirector, Chief Executive Officer
Option Exercise
114,351$60.8934,103(D)

View →

Mar 10, 2026Mar 11 8:18 PMKyle JenneEVP, Chf GL Pdt Str Ofcr
Option Exercise
37,277$46.1032,601(D)

View →

Mar 4, 2026Mar 5 11:14 PMJoseph LoscalzoDirector
Option Exercise
200$38.0610,968(D)

View →

Mar 3, 2026Mar 5 11:14 PMJoseph LoscalzoDirector
Option Exercise
832$38.0611,168(D)

View →

Mar 3, 2026Mar 5 11:14 PMJoseph Klein IIIDirector
Option Exercise
16,000$42.880(D)

View →

Mar 3, 2026Mar 5 11:14 PMAllene M. DiazDirector
Option Exercise
40,321$41.080(D)

View →

Mar 3, 2026Mar 5 11:14 PMShannon L. DeversEVP, Chief Human Resources Ofc
Option Exercise
20,106$52.878,877(D)

View →

Mar 3, 2026Mar 5 11:13 PMBENNETT C FRANKEVP, Chief Scientific Officer
Option Exercise
65,089$60.890(D)

View →

Mar 4, 2026Mar 5 11:13 PMJoseph BaroldiEVP, Chief Business Officer
Option Exercise
439$56.783,866(I)

View →

Mar 3, 2026Mar 5 11:13 PMJoseph BaroldiEVP, Chief Business Officer
Option Exercise
1,699$56.784,104(I)

View →

Feb 2, 2026Feb 4 9:06 PMBENNETT C FRANKEVP, Chief Scientific Officer
Option Exercise
65,089$60.890(D)

View →

Jan 15, 2026Jan 21 1:21 AMMichael J. YangDirector
Option Exercise
1,9307,150(D)

View →

Jan 15, 2026Jan 21 1:21 AMEric SwayzeEVP Research
Grant/Award
35,700$0.00611(I)

View →

Jan 15, 2026Jan 21 1:21 AMEric SwayzeEVP Research
Option Exercise
21,477386(I)

View →

Jan 15, 2026Jan 21 1:21 AMEugene SchneiderEVP, Chf Clinical Develop Ofcr
Option Exercise
21,68539,251(D)

View →

Jan 15, 2026Jan 21 1:21 AMEugene SchneiderEVP, Chf Clinical Develop Ofcr
Grant/Award
35,475$0.0048,926(D)

View →

Jan 15, 2026Jan 21 1:20 AMPatrick R. O'NeilEVP CLO & General Counsel
Option Exercise
21,47339,251(D)

View →

Jan 15, 2026Jan 21 1:20 AMPatrick R. O'NeilEVP CLO & General Counsel
Grant/Award
35,475$0.0048,926(D)

View →

Jan 15, 2026Jan 21 1:20 AMBrett P MoniaDirector, Chief Executive Officer
Grant/Award
156,585$0.00205,719(D)

View →

Jan 15, 2026Jan 21 1:20 AMBrett P MoniaDirector, Chief Executive Officer
Option Exercise
89,145163,014(D)

View →